CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc.

1:16-cv-00465

Overview

Case Number 1:16-cv-00465
Filing Date 2016-06-20
Status Terminated
Termination Date 2019-10-07
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Hisamitsu Pharmaceutical Co., Inc. NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Actavis Laboratories UT, Inc. Operating Company

Represented By

2 Attorneys Listed

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Noven Pharmaceuticals, Inc. Operating Company

Represented By

3 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 19 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (19): πŸ‡¨πŸ‡¦ Canada πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8231906
Transdermal estrogen device and delivery
Filed: 2008-07-10
Issued: 2012-07-31
Active (3.6 yrs remaining) +724d PTA
Expires: 2030-07-04

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+724 days) / Cellect Scrutiny β€” Over 724 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 7 STIPULATION TO EXTEND TIME for Actavis to move, answer or otherwise respond to the Complaint to July 26, 2016 filed by Actavis Laboratories UT,...
Entry #β€” • 2016-07-14
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Actavis to move, answer or otherwise respond to the Complaint to July 26, 2016 - filed by Actavis Laboratories UT, Inc.. (Mowery,...
Entry #7 • 2016-07-12 Document →

Docket Entries

(35 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Actavis Laboratories UT, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1950046.) - filed by Noven Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cna) (Entered: 06/20/2016)

Entry #1 • 2016-06-20
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cna) (Entered: 06/20/2016)

Entry #2 • 2016-06-20
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/6/2016. Date of Expiration of Patent: 7/4/2030.Thirty Month Stay Deadline: 12/6/2018. (cna) (Entered: 06/20/2016)

Entry #3 • 2016-06-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,231,906. (cna) (Entered: 06/20/2016)

Entry #4 • 2016-06-20
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hisamitsu Pharmaceutical Company, Inc. for Noven Pharmaceuticals, Inc. filed by Noven Pharmaceuticals, Inc.. (cna) (Entered: 06/20/2016)

Entry #5 • 2016-06-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc